The brands add to core markets Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, along with its subsidiaries together referred to as Dr. Reddy’s) has entered into a definitive agreement with Glenmark Pharmaceuticals Ltd to acquire, subject to...
Read moreDetails










